companydata.dkcompanydata.dk

SERA-SCANDIA A/S: Financial statements 2023

CVR: 14605185

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 41,875,000 and a net result of DKK 2,988,000 compared with DKK 11,427,000 the year before. That is a decrease of 10.7% compared with the year before. Equity in the 2023 report amounted to DKK 291,439,000. The solvency ratio was 61.5%. The company had 273 employees in the financial year.

Gross Profit
DKK 41,875,000
Profit/Loss
DKK 2,988,000
Equity
DKK 291,439,000
Total Assets
DKK 473,644,000
Employees
273

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-41.9M3M291.4M273
2022-46.9M11.4M83.1M274
2021242.3M28.7M16.1M62M176
20203.7M433K-16.6M50.3M186
20192.7M683K-9.9M66.9M207

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Jørn Martin Bank leaves the board of SERA-SCANDIA A/SNov 1, 2023

As of November 1, 2023, Jørn Martin Bank has left the board of directors of SERA-SCANDIA A/S.

SERA-SCANDIA A/S: The 2022 annual report is outJul 10, 2023

SERA-SCANDIA A/S has published its annual report for 2022. Gross profit came to DKK 46,880,000, and the net result was DKK 11,427,000.

Nicolas Bødtker Nielsen joins the board of SERA-SCANDIA A/SMar 21, 2023

As of March 21, 2023, Nicolas Bødtker Nielsen has joined the board of directors of SERA-SCANDIA A/S.

About SERA-SCANDIA A/S

SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.

Source: annual report 2025, Danish Business Authority